Stemsation International Current Valuation vs. Total Asset

STSN Stock  USD 0.02  0.01  33.75%   
Taking into consideration Stemsation International's profitability measurements, Stemsation International may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Stemsation International's ability to earn profits and add value for shareholders.
For Stemsation International profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Stemsation International to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Stemsation International utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Stemsation International's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Stemsation International over time as well as its relative position and ranking within its peers.
  
Check out World Market Map.
Please note, there is a significant difference between Stemsation International's value and its price as these two are different measures arrived at by different means. Investors typically determine if Stemsation International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stemsation International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Stemsation International Total Asset vs. Current Valuation Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Stemsation International's current stock value. Our valuation model uses many indicators to compare Stemsation International value to that of its competitors to determine the firm's financial worth.
Stemsation International is currently regarded number one company in current valuation category among its peers. It is rated below average in total asset category among its peers . The ratio of Current Valuation to Total Asset for Stemsation International is about  1,984 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Stemsation International by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Stemsation International's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Stemsation Current Valuation vs. Competition

Stemsation International is currently regarded number one company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Drug Manufacturers—Specialty & Generic industry is at this time estimated at about 7.18 Billion. Stemsation International adds roughly 3.81 Million in current valuation claiming only tiny portion of equities under Drug Manufacturers—Specialty & Generic industry.

Stemsation Total Asset vs. Current Valuation

Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Stemsation International

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
3.81 M
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.

Stemsation International

Total Asset

 = 

Tangible Assets

+

Intangible Assets

 = 
1.92 K
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.

Stemsation Total Asset Comparison

Stemsation International is currently under evaluation in total asset category among its peers.

Stemsation International Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Stemsation International, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Stemsation International will eventually generate negative long term returns. The profitability progress is the general direction of Stemsation International's change in net profit over the period of time. It can combine multiple indicators of Stemsation International, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
StemSation International, Inc. develops, manufactures, and distributes natural wellness products that support the stem cell and endocannabinoid systems in the human body. StemSation International, Inc. is headquartered in Boca Raton, Florida. Sternsation International operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.

Stemsation Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Stemsation International. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Stemsation International position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Stemsation International's important profitability drivers and their relationship over time.

Learn to be your own money manager

Our tools can tell you how much better you can do entering a position in Stemsation International without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Sectors Now

   

Sectors

List of equity sectors categorizing publicly traded companies based on their primary business activities
All  Next Launch Module

Use Investing Themes to Complement your Stemsation International position

In addition to having Stemsation International in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Consumer Funds Thematic Idea Now

Consumer Funds
Consumer Funds Theme
Funds or Etfs that invest in consumer products such as packaged goods, clothing, food, beverages and retail services. The Consumer Funds theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Consumer Funds Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Stemsation Pink Sheet

To fully project Stemsation International's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Stemsation International at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Stemsation International's income statement, its balance sheet, and the statement of cash flows.
Potential Stemsation International investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Stemsation International investors may work on each financial statement separately, they are all related. The changes in Stemsation International's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Stemsation International's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.